Filtrer efter Last updated date SelectEfterFørFrom - To Dato Slutdato Denne uge Denne måned Seneste uge Seneste måned Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationResearch and developmentMedicine shortagesBiosimilarsSMEAntimicrobial resistanceGovernanceBrexitQuality of medicinesCorporateGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationScientific adviceMedical devicesMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate useCareersMedication errorParallel distributionPRIMEProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety Yes Efterlad dette felt tomt Filter Resultater (3800) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Efterlad dette felt tomt COVID-19: EMA recommends conditional marketing authorisation for Paxlovid 28 januar 2022NewsHumanCOVID-19Medicines New EU rules for safe and high-quality medicines for animals become effective 28 januar 2022NewsVeterinaryRegulatory and procedural guidanceMedicines Regulatory harmonisation of clinical trials in the EU: Clinical Trials Regulation to enter into application and new Clinical Trials Information System to be launched 25 januar 2022NewsHumanClinical trials Increase in manufacturing capacity for Vaxzevria (previously COVID-19 Vaccine AstraZeneca) 24 januar 2022NewsHumanCOVID-19Vaccines Meeting highlights from the Committee for Medicinal Products for Veterinary Use (CVMP) 18-19 January 2022 21 januar 2022NewsVeterinaryMaximum residue limitMedicines International regulators’ recommendations on COVID-19 vaccines and the Omicron variant 21 januar 2022NewsHumanCOVID-19 COVID-19: latest safety data provide reassurance about use of mRNA vaccines during pregnancy 18 januar 2022NewsHumanCOVID-19Vaccines Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 10 - 13 January 2022 14 januar 2022NewsHumanCOVID-19PharmacovigilanceReferralsVaccines EMA welcomes EU Commissioner for Health and Food Safety 13 januar 2022NewsCorporateCOVID-19 Accelerating Clinical Trials in the EU (ACT EU): for better clinical trials that address patients’ needs 13 januar 2022NewsHumanClinical trials 1 … 47 48 49 50 51 Page 51 of 380 52 53 54 55 … 380
COVID-19: EMA recommends conditional marketing authorisation for Paxlovid 28 januar 2022NewsHumanCOVID-19Medicines
New EU rules for safe and high-quality medicines for animals become effective 28 januar 2022NewsVeterinaryRegulatory and procedural guidanceMedicines
Regulatory harmonisation of clinical trials in the EU: Clinical Trials Regulation to enter into application and new Clinical Trials Information System to be launched 25 januar 2022NewsHumanClinical trials
Increase in manufacturing capacity for Vaxzevria (previously COVID-19 Vaccine AstraZeneca) 24 januar 2022NewsHumanCOVID-19Vaccines
Meeting highlights from the Committee for Medicinal Products for Veterinary Use (CVMP) 18-19 January 2022 21 januar 2022NewsVeterinaryMaximum residue limitMedicines
International regulators’ recommendations on COVID-19 vaccines and the Omicron variant 21 januar 2022NewsHumanCOVID-19
COVID-19: latest safety data provide reassurance about use of mRNA vaccines during pregnancy 18 januar 2022NewsHumanCOVID-19Vaccines
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 10 - 13 January 2022 14 januar 2022NewsHumanCOVID-19PharmacovigilanceReferralsVaccines
Accelerating Clinical Trials in the EU (ACT EU): for better clinical trials that address patients’ needs 13 januar 2022NewsHumanClinical trials